Venture Capital & Emerging Companies

The New York LLC Transparency Act, which takes effect on January 1, 2026, will require limited liability companies formed or authorized to do business in New York to make certain disclosures aimed at preventing the use of anonymous LLCs for illicit activities.

Join Mintz Corporate and Securities Associate, Jason Miller, in a conversation with Margaret Yu, founder and CEO of Reliacare, and Andrew Gladue, founder and CEO of Plethys.

This issue of MintzTech Connect covers Corporate Transparency Act compliance requirements, considerations for companies undertaking Section 409A valuations, and Mintz’s year in review of laws impacting employee non-competition, non-solicitation, and non-disclosure agreements.

As a start-up begins to approach its fiscal year-end, company founders need to be mindful of key annual action items for boards, such as the budget, executive compensation, and other administrative actions.

The New York LLC Transparency Act, which takes effect on December 21, 2024, will require limited liability companies formed or authorized to do business in New York to make certain disclosures aimed at preventing the use of anonymous LLCs for illicit activities.

In this episode of Client Corner, Josh speaks to Suono Bio’s CEO Scott Kellogg and COO Skip Farinha. Scott and Skip discuss the importance of active listening in managing a team, strategies for navigating the medical device approval process in the US, key factors to consider when selecting investors, and insights on managing unforeseen challenges.

In this episode of Client Corner, Josh speaks to Paul Le Floch, Co-founder & CEO of Axoft. Paul discusses his journey from growing up in France to becoming a founder and the CEO of a neurotechnology startup. He provides insight into forming Axoft and navigating the fundraising process and offers advice to individuals starting new ventures.

This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in 2023. Mintz represented issuers and investors in the technology, energy, life sciences, and other sectors in more than 130 transactions valued at over $2.6 billion. 

Reporting requirements under the Corporate Transparency Act (CTA) are in effect beginning January 1, 2024.  Under the CTA, many US entities will be required to provide the personal information of their beneficial owners to the Financial Crimes Enforcement Network (FinCEN), a division of the US Treasury Department.

In this article, we explore the intricacies of 409A valuations, focusing on their importance, timing, and methodologies, and offer strategies for challenging valuations — assuming reliance on third-party assessments.

In this episode of Client Corner, Josh speaks to Gio Traverso, MIT professor, founder of several biotech companies, and a physician. Gio discusses his experience starting six different companies with Josh, comprising both for-profit and nonprofit entities. He reflects upon the process of deciding whether to start a business using a nonprofit or a for-profit structure, bringing together a strong team, evaluating potential investors, and licensing intellectual property from a university.

This issue of MintzTech Connect covers a Globe and Mail piece on Mintz’s continued expansion in Toronto, Biden’s executive order on artificial intelligence, Forbes magazine’s recognition of Moolah Kicks founder Natalie White’s inclusion on its “30 Under 30” list, and our Client Corner podcast featuring a conversation with NextGen Jane Co-founder & CEO Ridhi Tariyal.

In this week’s episode of Client Corner, Josh speaks to Carlos Araque, Co-founder and CEO of Quaise Energy. Carlos discusses his motivation in developing Quaise Energy and his guiding philosophy of impact over probability of success. He provides advice to other first-time CEOs and offers insights on the state of diversity in the technology sector.

As reported in Forbes, Natalie White was recognized as a “30 under 30” for Sports.  Natalie founded Moolah Kicks, the first basketball shoe brand focused solely on women. 

In this week’s episode of Client Corner, Member and Host Josh Fox chats with Anna Turetsky, Principal, Venture Investments for the Mark Foundation for Cancer Research.

In this episode of Client Corner, Josh chats with Rahul Dhanda, co-founder and CEO of Syntis Bio, a late-stage, preclinical company developing a new class of therapy.

In this episode of Client Corner, Josh chats with John Edwards, an executive chair, board member, and senior adviser to start-up and clinical-stage biotechnology companies.

In this episode of Client Corner, Member Josh Fox talks with NextGen Jane’s Co-founder and CEO, Ridhi Tariyal about how the company is using precision medicine to transform obstetric and gynecological care.

In this episode of Client Corner, Joshua Fox chats with Jerry Williamson, CEO of Sengenics. Jerry has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products.